We are developing target specific drugs for skin cancer prevention. Presently we are targeting a unique feature of UV light induced damage in skin dermal proteins in the extracellular matrix, such as collagen, that absorb light and generate ROS. We are also developing agents that scavenge reactive carbonyl species formed in skin by UV light. These studies span both basic and translational aspects of skin cancer prevention.